APLS vs MSFT: Which Stock is Better?
Side-by-side comparison of Apellis Pharmaceuticals Inc and Microsoft Corp in 2026
APLS
Apellis Pharmaceuticals Inc
$40.88
MSFT
Microsoft Corp
$396.65
Key Metrics Comparison
| Metric | APLS | MSFT | Winner |
|---|---|---|---|
| Market Cap | $5.22B | N/A | APLS |
| P/E Ratio | 226.94 | 24.57 | MSFT |
| EPS (TTM) | $0.18 | $16.00 | MSFT |
| Revenue Growth | -0.1% | 0.2% | MSFT |
| Gross Margin | 60.3% | 68.6% | MSFT |
Analyze APLS
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is APLS or MSFT a better investment?
Comparing APLS and MSFT: Apellis Pharmaceuticals Inc has a market cap of $5.22B while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between APLS and MSFT?
APLS (Apellis Pharmaceuticals Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: APLS or MSFT?
Based on P/E ratios, MSFT trades at a lower multiple (24.6x vs 226.9x).
Which is growing faster: APLS or MSFT?
MSFT has higher revenue growth at 0.2% vs -0.1% for APLS.
Which company is more profitable: APLS or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to 60.3% for APLS.
Which is the larger company: APLS or MSFT?
Apellis Pharmaceuticals Inc (APLS) is larger with a market cap of $5.22B compared to N/A for MSFT.
Should I buy APLS or MSFT in 2026?
Both APLS and MSFT have investment merit. APLS trades at $40.88 while MSFT trades at $396.65. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between APLS and MSFT stock?
Key differences: Market Cap ($5.22B vs N/A), P/E Ratio (226.9x vs 24.6x), Revenue Growth (-0.1% vs 0.2%), Gross Margin (60.3% vs 68.6%).